OrthoPediatrics Corp (KIDS)

OrthoPediatrics (KIDS) Income Statement


OrthoPediatrics Income Statement

Last quarter (Q4 2023), OrthoPediatrics's total revenue was $37.61M, an increase of 21.36% from the same quarter last year. In Q4, OrthoPediatrics's net income was $-6.69M. See OrthoPediatrics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 148.73M$ 148.73M$ 122.29M$ 98.05M$ 71.08M$ 72.55M
Cost of Revenue
$ 37.48M$ 37.48M$ 31.63M$ 24.65M$ 16.05M$ 17.93M
Gross Profit
$ 111.25M$ 111.25M$ 90.66M$ 73.40M$ 55.03M$ 54.62M
Operating Expense
$ 138.00M$ 138.00M$ 116.06M$ 91.28M$ 75.44M$ 63.70M
Operating Income
$ -26.75M$ -26.75M$ -25.40M$ -17.87M$ -20.41M$ -9.08M
Net Non Operating Interest Income Expense
$ -12.00K$ 198.00K$ -2.42M$ -2.25M$ -3.41M$ -3.54M
Other Income Expense
$ -4.26M$ -4.26M$ -20.52M$ -2.88M$ -9.84M$ -70.00K
Pretax Income
$ -21.31M$ -21.31M$ -3.69M$ -17.39M$ -33.67M$ -12.69M
Tax Provision
$ -338.00K$ -338.00K$ -4.95M$ -1.13M$ -723.00K$ 0.00
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -20.97M$ -20.97M$ 1.26M$ -16.26M$ -32.94M$ -13.73M
Basic EPS
$ -0.92$ -0.92$ 0.06$ -0.84$ -1.82$ -0.94
Diluted EPS
$ -0.92$ -0.92$ 0.06$ -0.84$ -1.82$ -0.94
Basic Average Shares
$ 90.70M$ 22.68M$ 20.70M$ 19.27M$ 18.06M$ 14.62M
Diluted Average Shares
$ 90.70M$ 22.68M$ 20.95M$ 19.27M$ 18.06M$ 14.62M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 175.48M$ 175.48M$ 147.69M$ 115.92M$ 91.49M$ 81.63M
Net Income From Continuing And Discontinued Operation
$ -20.97M$ -20.97M$ 1.26M$ -16.26M$ -32.94M$ -13.73M
Normalized Income
$ -21.71M$ -23.46M$ -32.89M-$ -23.29M$ -12.69M
Interest Expense
----$ 3.41M$ 3.54M
$ -21.30M$ -21.51M$ -1.26M$ -15.14M$ -30.25M$ -9.15M
$ -4.46M$ -4.13M$ 11.83M$ -4.46M$ -22.25M$ -4.48M
Currency in USD

OrthoPediatrics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis